Evidence map›Paper›PMID 39951344›Full record

ArticleKidney3602025

Renal Phenotype Variations among Families with Autosomal Alport Syndrome: Potential Role of Modifier Genes.

Abdelrahman Ibrahim, Edwin Lin, Mack Hinckley, Mazdak Khalighi, Zena Altawallbeh, Daher Al-Rabadi, Zakariya Al-Hassanat, Marcus G Pezzolesi, Martin C Gregory, Laith Al-Rabadi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdelrahman IbrahimNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.ORCID 0000-0002-2661-4882
Edwin LinInternal Medicine Department, University of Utah Health, Salt Lake City, Utah.
Mack HinckleyNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.
Mazdak KhalighiDermatology Department, University of Utah Health, Salt Lake City, Utah.
Zena AltawallbehNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.
Daher Al-RabadiFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0001-5146-9544
Zakariya Al-HassanatFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Marcus G PezzolesiNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.
Martin C GregoryNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.ORCID 0000-0002-7323-7653
Laith Al-RabadiNephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah.ORCID 0000-0002-2225-9721

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen EpitopesK23DK132487 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Laith Al-Rabadi · 2023 to 2026
$701k
Center for Clinical and Translational Science, University of UtahNCATS NIH HHS UM1 TR004409NIDDK NIH HHS K23 DK132487
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alport syndrome

Identifiers

PMID39951344
PMCPMC12136652

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.